Kitov Pharma Ltd (KTOV.OQ)
KTOV.OQ on NASDAQ Stock Exchange Capital Market
Change (% chg)
Revenue & Earnings Per Share
Consensus Estimates Analysis
No consensus analysis data available.
Performance for Kitov Pharma Ltd
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Kitov Pharma Files Stock Shelf Of Up To 28 Million Adss By Selling Shareholders
- BRIEF-Kitov Announces Initiation Of Phase 1/2 Clinical Trial Of NT219 In Advanced Cancer Patients
- BRIEF-Kitov Pharma Receives Notice Of Intention To Grant A European Patent Covering Cm24, Its Anti-Ceacam1 Antibody
- BRIEF-Kitov Pharma Issues CEO Shareholder Letter Providing Business Update
- BRIEF-Kitov Announces $35.0 Million Registered Direct Offering
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.